EUCTR2016-002602-39-NL进行中（未招募）1 期
FGF23 response in hypophosphatemia
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •age older than 18 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •any medical history
- •inability to give informed consent
- •medication use (except from oral contraceptives)
研究者
相似试验
已完成
不适用
FGF23 response in hypophosphatemialow bood phosphate level10029149hypophosphatemiaNL-OMON42928Radboud Universitair Medisch Centrum10
招募中
不适用
phosphorus intake and FGF23 blood levelshet gaat om gezonde proefpersonenniet van toepassingNL-OMON31826Vrije Universiteit Medisch Centrum10
已完成
不适用
FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney DiseaseSecondary HyperparathyroidismNCT00999037University of California, Los Angeles18
已完成
不适用
FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)X-linked HypophosphatemiaRenin-angiotensin SystemLeft Ventricular HypertrophyHypophosphatemiaNCT03489993Wake Forest University Health Sciences8
已完成
不适用
Study of the Inappropriate Secretion of FGF23 in Patients Followed in Hospital in a Context of HypophosphatemiaHypophosphatemia Without Immediate AnteriorityUnexplained HypophosphatemiaNCT04846647University Hospital, Clermont-Ferrand260